Divi's Laboratories Limited (BOM:532488)
India · Delayed Price · Currency is INR 9,580.00
+35.00 (0.37%)
At close: Oct 7, 2026
Divi's Laboratories Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 2,545,313 | 1,578,742 | 1,533,201 | 914,619 | 749,511 | 1,168,606 | |
Market Cap Growth | 63.45% | 2.97% | 67.63% | 22.03% | -35.86% | 21.51% |
Enterprise Value | 2,513,053 | 1,547,032 | 1,497,261 | 878,559 | 716,177 | 1,149,850 |
Last Close Price | 9580.00 | 5922.12 | 5723.33 | 3386.35 | 2762.01 | 4271.78 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 87.02 | 61.48 | 69.98 | 57.16 | 41.09 | 39.47 |
PS Ratio | 22.67 | 14.95 | 16.38 | 11.66 | 9.65 | 13.04 |
PB Ratio | 15.19 | 9.42 | 10.24 | 6.74 | 5.87 | 9.96 |
P/TBV Ratio | 15.19 | 9.42 | 10.25 | 6.74 | 5.87 | 9.97 |
P/FCF Ratio | 1167.57 | 724.19 | 713.12 | 354.50 | 37.74 | 97.50 |
P/OCF Ratio | 92.96 | 57.66 | 92.75 | 72.53 | 30.48 | 61.13 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 22.38 | 14.65 | 16.00 | 11.20 | 9.22 | 12.83 |
EV/EBITDA Ratio | 63.36 | 45.00 | 50.45 | 39.84 | 30.30 | 29.64 |
EV/EBIT Ratio | 72.01 | 51.95 | 58.26 | 47.98 | 35.35 | 32.19 |
EV/FCF Ratio | 1152.78 | 709.65 | 696.40 | 340.53 | 36.06 | 95.93 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / EBITDA Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Debt / FCF Ratio | - | 0.03 | 0.02 | 0.01 | 0.00 | 0.00 |
Net Debt / Equity Ratio | -0.19 | -0.19 | -0.23 | -0.27 | -0.32 | -0.23 |
Net Debt / EBITDA Ratio | -0.81 | -0.94 | -1.19 | -1.68 | -1.75 | -0.71 |
Net Debt / FCF Ratio | - | -14.80 | -16.39 | -14.32 | -2.08 | -2.28 |
Asset Turnover | - | 0.57 | 0.58 | 0.53 | 0.56 | 0.74 |
Inventory Turnover | - | 1.20 | 1.23 | 1.09 | 1.12 | 1.27 |
Quick Ratio | - | 3.27 | 4.48 | 4.74 | 5.51 | 4.41 |
Current Ratio | - | 5.43 | 6.94 | 7.57 | 8.46 | 6.99 |
Return on Equity (ROE) | - | 16.19% | 15.35% | 12.15% | 14.89% | 28.16% |
Return on Assets (ROA) | - | 10.07% | 9.92% | 7.65% | 9.11% | 18.49% |
Return on Invested Capital (ROIC) | 19.67% | 18.07% | 18.11% | 14.63% | 17.70% | 35.43% |
Return on Capital Employed (ROCE) | - | 16.60% | 16.60% | 12.90% | 15.20% | 29.30% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 1.15% | 1.63% | 1.43% | 1.75% | 2.43% | 2.53% |
FCF Yield | 0.09% | 0.14% | 0.14% | 0.28% | 2.65% | 1.03% |
Dividend Yield | 0.31% | 0.51% | 0.52% | 0.89% | 1.09% | 0.70% |
Payout Ratio | - | 31.04% | 36.33% | 49.75% | 43.64% | 17.93% |
Total Shareholder Return | 0.39% | 0.51% | 0.52% | 0.89% | 1.09% | 0.70% |